Michael L. Cher
Experienced in Congenital Mesoblastic Nephroma

Dr. Michael L. Cher

Urology
Corewell Health
Wayne Health
5250 Auto Club Drive, Suite 290A, 
Dearborn, MI 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
40 Years of Experience
Experienced in Congenital Mesoblastic Nephroma
Corewell Health
Wayne Health
5250 Auto Club Drive, Suite 290A, 
Dearborn, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Cher is an Urologist in Dearborn, Michigan. Dr. Cher has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of Congenital Mesoblastic Nephroma. His top areas of expertise are Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Ureteral Reconstruction. Dr. Cher is currently accepting new patients.

His clinical research consists of co-authoring 83 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Washington School Of Medicine, 1986
Residency
University of Texas Southwestern Medical Center
Specialties
Urology
Licenses
Urology in MI
Board Certifications
American Board Of Urology
Fellowships
University of California, San Francisco, School of Medicine
Hospital Affiliations
Corewell Health Dearborn Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Wayne Health
5250 Auto Club Drive, Suite 290A, Dearborn, MI 48126
Call: 313-448-9220
Other Locations
Karmanos Cancer Institute at Weisberg Cancer Center - Farmington Hills
31995 Northwestern Highway, Farmington Hills, MI 48334
Call: 248-538-4701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
Enrollment Status: Recruiting
Publish Date: October 16, 2025
Intervention Type: Biological
Study Drugs: Bacillus of Calmette-Guerin, ALT-803
Study Phase: Phase 1/Phase 2
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drugs: ALT-803, Bacillus Calumette-Guerin
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trial

83 Total Publications

Reply by Authors.
Reply by Authors.
Journal: The Journal of urology
Published: October 24, 2025
View All 83 Publications
Similar Doctors
Brian D. Seifman
Distinguished in Congenital Mesoblastic Nephroma
Dr. Brian D. Seifman
Urology
Distinguished in Congenital Mesoblastic Nephroma
Dr. Brian D. Seifman
Urology

Michigan Institute Of Urology

1701 East South Blvd., Suite 340, 
Rochester Hills, MI 
 (23.5 miles away)
248-293-1000
Experience:
30+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brian Seifman is an Urologist in Rochester Hills, Michigan. Dr. Seifman has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Congenital Mesoblastic Nephroma. His top areas of expertise are Kidney Stones, Congenital Mesoblastic Nephroma, Enlarged Prostate (BPH), Ureteroscopy, and Lithotripsy. Dr. Seifman is currently accepting new patients.

Juan R. Frontera
Distinguished in Congenital Mesoblastic Nephroma
Dr. Juan R. Frontera
Urology
Distinguished in Congenital Mesoblastic Nephroma
Dr. Juan R. Frontera
Urology

Michigan Institute Of Urology

20952 12 Mile Rd, Suite 200, 
Saint Clair Shores, MI 
 (20.3 miles away)
586-771-4820
Experience:
41+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Juan Frontera is an Urologist in Saint Clair Shores, Michigan. Dr. Frontera has been practicing medicine for over 41 years and is rated as a Distinguished provider by MediFind in the treatment of Congenital Mesoblastic Nephroma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Frontera is currently accepting new patients.

Kenneth M. Kernen
Distinguished in Congenital Mesoblastic Nephroma
Dr. Kenneth M. Kernen
Urology
Distinguished in Congenital Mesoblastic Nephroma
Dr. Kenneth M. Kernen
Urology

Michigan Institute Of Urology

130 Town Center Drive, Suite 101, 
Troy, MI 
 (17.0 miles away)
248-740-0670
Experience:
33+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kenneth Kernen is an Urologist in Troy, Michigan. Dr. Kernen has been practicing medicine for over 33 years and is rated as a Distinguished provider by MediFind in the treatment of Congenital Mesoblastic Nephroma. His top areas of expertise are Prostate Cancer, Enlarged Prostate (BPH), Perirenal Abscess, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kernen is currently accepting new patients.

VIEW MORE CONGENITAL MESOBLASTIC NEPHROMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cher's expertise for a condition
ConditionClose
  • Elite
  • Prostate Cancer
    Dr. Cher is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Distinguished
  • Familial Prostate Cancer
    Dr. Cher is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Cher is
    Distinguished
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
  • Advanced
  • Bladder Cancer
    Dr. Cher is
    Advanced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Enlarged Prostate (BPH)
    Dr. Cher is
    Advanced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Muscle Invasive Bladder Cancer
    Dr. Cher is
    Advanced
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Prostatectomy
    Dr. Cher is
    Advanced
    . Learn about Prostatectomy.
    See more Prostatectomy experts
  • Renal Cell Carcinoma (RCC)
    Dr. Cher is
    Advanced
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Upper Tract Urothelial Carcinoma (UTUC)
    Dr. Cher is
    Advanced
    . Learn about Upper Tract Urothelial Carcinoma (UTUC).
    See more Upper Tract Urothelial Carcinoma (UTUC) experts
View All 8 Advanced Conditions
  • Experienced
  • Bilateral Hydronephrosis
    Dr. Cher is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Outlet Obstruction
    Dr. Cher is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bladder Stones
    Dr. Cher is
    Experienced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Carbuncle
    Dr. Cher is
    Experienced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Choriocarcinoma
    Dr. Cher is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Cher is
    Experienced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.